Ali Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Glycosylation and Glycoproteins Research 1
- Ubiquitin and proteasome pathways 1
-
- MicroRNA in disease regulation 1
- Co-authors
- Xiang Gu (4 shared papers)Xiaojun Chen (2 shared papers)Xiang Gu (1 shared paper)Pengfei Li (1 shared paper)Ping Li (1 shared paper)Xiaojun Chen (1 shared paper)Yue Xie (1 shared paper)Tao Wang (2 shared papers)
In The Last Decade
Ali Wang
7 papers receiving 96 citations
Peers
Comparison fields: 5 of 25
- Cancer Research 41
- Oncology 22
- Molecular Biology 52
- Immunology 15
- Pulmonary and Respiratory Medicine 17
Countries citing papers authored by Ali Wang
This map shows the geographic impact of Ali Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Wang more than expected).
Fields of papers citing papers by Ali Wang
This network shows the impact of papers produced by Ali Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Wang. The network helps show where Ali Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 32 | |
| 2 | 2020 | 24 | |
| 3 | 2022 | 18 | |
| 4 | 2019 | 17 | |
| 5 | 2020 | 2 | |
| 6 | 2025 | 2 | |
| 7 | 2018 | 1 |
About Ali Wang
Ali Wang is a scholar working on Molecular Biology, Cancer Research, Immunology, Pulmonary and Respiratory Medicine and Oncology, having authored 7 papers that have together received 96 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (1 paper), Nanoplatforms for cancer theranostics (1 paper), Glycosylation and Glycoproteins Research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Ferroptosis and cancer prognosis (1 paper), Immunotherapy and Immune Responses (1 paper), Ubiquitin and proteasome pathways (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (41 citations), Oncology (22 citations), Molecular Biology (52 citations), Immunology (15 citations) and Pulmonary and Respiratory Medicine (17 citations). Ali Wang has collaborated with scholars based in China and Germany. Frequent co-authors include Xiang Gu, Xiaojun Chen, Xiang Gu, Pengfei Li, Ping Li, Xiaojun Chen, Yue Xie, Ping Li, Tao Wang and Pengfei Li. Their work appears in journals such as Cell Proliferation, Molecular Therapy — Nucleic Acids, Journal of Cellular and Molecular Medicine, Archives of Biochemistry and Biophysics and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.